Fig. 5

The combination of c-Myc and TGF-β1 was found to enhance prognostic accuracy for HCC. Disease-free survival curves (a, P < 0.001, log-rank test) and overall survival curves (b, P < 0.001, log-rank test)
The combination of c-Myc and TGF-β1 was found to enhance prognostic accuracy for HCC. Disease-free survival curves (a, P < 0.001, log-rank test) and overall survival curves (b, P < 0.001, log-rank test)